Section 4.100 - Application of the general rating formula for diseases of the heart(a) Whether or not cardiac hypertrophy or dilatation (documented by electrocardiogram, echocardiogram, or X-ray) is present and whether or not there is a need for continuous medication must be ascertained in all cases.(b) Even if the requirement for a 10% (based on the need for continuous medication) or 30% (based on the presence of cardiac hypertrophy or dilatation) evaluation is met, METs testing is required in all cases except: (1) When there is a medical contraindication.(2) When a 100% evaluation can be assigned on another basis. 71 FR 52460 , Sept. 6, 2006, as amended at 86 FR 54093 , Sept. 30, 2021; 86 FR 67654 , Nov. 29, 2021 Authority: 38 U.S.C. 1155
86 FR 54089, 11/14/2021; 86 FR 62095, 11/14/2021; 86 FR 67654, 11/29/2021